AMS.L Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (8 geg. 2024 @ 17:56):

Stats
Dzisiejszy wolumen	160 252
Średni wolumen	664 874
Kapitalizacja rynkowa	430.14M
EPS	£0 ( 2024-03-16 )
Last Dividend	£1.510 ( 2023-05-18 )
Next Dividend	£0 ( N/A )
P/E	28.31
ATR14	£0.897 (0.45%)

Wolumen Korelacja

Długi: 0.04 (neutral)

Krótki: 0.19 (neutral)

Signal:(54.766) Neutral

Advanced Medical Korelacja

10 Najbardziej pozytywne korelacje
EJFI.L	0.861
PSON.L	0.855
VSL.L	0.845
ALL.L	0.841
NAIT.L	0.84
WIN.L	0.837
MIG.L	0.836
BEZ.L	0.836
LXI.L	0.834
DHSD.L	0.833

10 Najbardziej negatywne korelacje
TFG.L	-0.877
UD04.L	-0.855
OCTP.L	-0.851
7DIG.L	-0.836
UAI.L	-0.835
FAN.L	-0.818
CALL.L	-0.805

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Advanced Medical Korelacja - Waluta/Towar

0.78
( moderate )

0.69
( moderate )

0.50
( neutral )

0.40
( neutral )

-0.42
( neutral )

0.80
( moderate )

Advanced Medical Finanse

Annual	2023
Przychody:	£126.21M
Zysk brutto:	£63.73M (50.49 %)
EPS:	£0.0736

FY	2023
Przychody:	£126.21M
Zysk brutto:	£63.73M (50.49 %)
EPS:	£0.0736

FY	2022
Przychody:	£124.33M
Zysk brutto:	£68.62M (55.19 %)
EPS:	£0.0942

FY	2021
Przychody:	£108.60M
Zysk brutto:	£61.07M (56.23 %)
EPS:	£0.0813

Financial Reports:

No articles found.

Advanced Medical Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
£0.640 (N/A)	£0 (N/A)	£0 (N/A)	£1.510 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)

Advanced Medical Dividend Information - Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 6.64 - Stable (32.83%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	£0.380	2011-05-11
Last Dividend	£1.510	2023-05-18
Next Dividend	£0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	26	--
Total Paid Out	£14.14	--
Avg. Dividend % Per Year	0.41%	--
Score	4.13	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	6.64
Div. Directional Score	9.02	--

Next Divdend (Est)
(2024-09-23)

£0 Estimate 3.72 %

Dividend Stability

0.30 Very Poor

Dividend Score

4.13

Pay Frequency

Semi-Annually

Yearly Payout

Year	Amount	Yield
2011	£0.525	0.72%
2012	£0.475	0.51%
2013	£0.540	0.85%
2014	£0.630	0.57%
2015	£0.730	0.58%
2016	£0.850	0.48%
2017	£0.970	0.44%
2018	£1.170	0.38%
2019	£1.400	0.51%
2020	£1.550	0.53%
2021	£1.780	0.73%
2022	£2.01	0.61%
2023	£1.510	0.57%
2024	£0	0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for LSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
TRI.L	Dividend Junior	2023-09-28	Annually	31	0.71%
MATE.L	Dividend Knight	2023-06-29	Quarterly	7	2.31%
CRH.L	Dividend Knight	2023-10-19	Semi-Annually	31	2.09%
S32.L	Dividend Junior	2023-09-14	Semi-Annually	9	1.97%
HLMA.L	Dividend Knight	2023-07-13	Semi-Annually	32	0.43%
BAKK.L	Dividend Knight	2023-09-14	Annually	7	4.28%
W7L.L	Dividend Knight	2023-11-09	Annually	8	2.69%
MTVW.L	Dividend Knight	2023-07-06	Semi-Annually	32	2.55%
DRX.L	Dividend Knight	2023-08-24	Semi-Annually	19	2.48%
SMS.L	Dividend Knight	2023-07-06	Quarterly	13	2.02%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.126	1.500	7.48	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0549	1.200	8.17	9.80	[0 - 0.3]
returnOnEquityTTM	0.0653	1.500	-0.386	-0.579	[0.1 - 1]
payoutRatioTTM	0.301	-1.000	6.99	-6.99	[0 - 1]
currentRatioTTM	5.67	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	4.00	0.800	10.00	8.00	[0.8 - 2.5]
cashRatioTTM	2.79	1.500	10.00	10.00	[0.2 - 2]
debtRatioTTM	0.0316	-1.500	9.47	-10.00	[0 - 0.6]
interestCoverageTTM	11.88	1.000	6.71	6.71	[3 - 30]
operatingCashFlowPerShareTTM	0.0662	2.00	9.98	10.00	[0 - 30]
freeCashFlowPerShareTTM	0.0211	2.00	9.99	10.00	[0 - 20]
debtEquityRatioTTM	0.0374	-1.500	9.85	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.505	1.000	4.92	4.92	[0.2 - 0.8]
operatingProfitMarginTTM	0.142	1.000	9.16	9.16	[0.1 - 0.6]
cashFlowToDebtRatioTTM	1.582	1.000	2.32	2.32	[0.2 - 2]
assetTurnoverTTM	0.436	0.800	-0.424	-0.339	[0.5 - 2]
Total Score				11.40

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	26.76	1.000	7.40	0	[1 - 100]
returnOnEquityTTM	0.0653	2.50	-0.248	-0.579	[0.1 - 1.5]
freeCashFlowPerShareTTM	0.0211	2.00	9.99	10.00	[0 - 30]
dividendYielPercentageTTM	1.135	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	0.0662	2.00	9.98	10.00	[0 - 30]
payoutRatioTTM	0.301	1.500	6.99	-6.99	[0 - 1]
pegRatioTTM	58.84	1.500	10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.115	1.000	9.64	0	[0.1 - 0.5]
Total Score				6.64

Advanced Medical

Advanced Medical Solutions Group plc, together with its subsidiaries, designs, develops, manufactures, and distributes products for the wound care, surgical, and wound closure markets in the United Kingdom, Germany, France, rest of Europe, the United States, and internationally. It operates in two segments, Surgical and Woundcare. The Surgical segment offers topical tissue adhesives for wound closure and sealing under the LiquiBand brand; sutures and collagen-based products for the surgical and dental markets under the RESORBA brand; collagens; and laparoscopic device used to fix hernia meshes placed inside the body under the LiquiBand Fix8 brand, as well as internal sealants under the Seal-G/Seal-G MIST brand. The Woundcare segment provides wound care platform technologies, which include alginates, foams, films, fibres, hydrogels, antimicrobial dressings, and hydrocolloids, as well as wound care products under the ActivHeal brand. Advanced Medical Solutions Group plc was incorporated in 1991 and is headquartered in Winsford, the United Kingdom.